Assoc Prof Dr. Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Associate Professor and UFG, Brazil

Assoc. Prof. Dr. Ricardo Menegatti is an Associate Professor at the Faculty of Pharmacy, Federal University of Goiás (UFG), Brazil. His academic journey began with a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC), followed by a Master’s degree in Chemistry and a Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ). His doctoral research focused on the design, synthesis, and pharmacological evaluation of novel neuroactive drug prototypes. Dr. Menegatti’s expertise spans various aspects of medicinal chemistry, including the development of new pharmacological agents, medicinal chemistry, and pharmaceutical analysis. He has been actively involved in teaching and research since joining UFG in 2006, where he has contributed to the development of courses in medicinal chemistry, pharmaceutical analysis, and organic chemistry. His work also includes extensive contributions to the university’s extension activities, such as coordinating workshops and seminars on pharmaceutical chemistry. Dr. Menegatti has a robust record of publications and presentations in his field, and his research interests primarily revolve around the synthesis of novel pharmacological agents and the application of advanced chemical techniques in drug development.

Profile

ORCID Profile

Education

Dr. Ricardo Menegatti holds a distinguished educational background in the field of pharmacy and chemistry. He earned his Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC) in 1998, where his research focused on leprosy. He then pursued advanced studies at the Federal University of Rio de Janeiro (UFRJ), obtaining a Master’s degree in Chemistry in 2001. His master’s research, under the guidance of Eliezer Jesus Barreiro, involved the design, synthesis, and pharmacological evaluation of new antipsychotic drug candidates, specifically targeting schizophrenia. Dr. Menegatti further advanced his expertise by completing a Ph.D. in Chemistry at UFRJ in 2005, focusing on the planning, synthesis, and pharmacological assessment of neuroactive drug prototypes, particularly in the areas of GABA, hypnotics, and analgesics. His doctoral research, also mentored by Eliezer J. Barreiro, was supported by the National Council for Scientific and Technological Development (CNPq), reflecting his commitment to advancing pharmaceutical sciences.

Professional Experience

Dr. Ricardo Menegatti is a seasoned academic and researcher with a strong background in pharmaceutical chemistry and medicinal compounds. He holds a Doctorate in Chemistry from the Federal University of Rio de Janeiro, where his research focused on the design, synthesis, and pharmacological evaluation of neuroactive drug prototypes. Dr. Menegatti currently serves as a Professor at the Faculty of Pharmacy, Federal University of Goiás, Brazil, where he has been a dedicated faculty member since 2006. His expertise lies in planning and synthesizing biologically active compounds, particularly those targeting neuroactive and antipsychotic pathways. In addition to his teaching responsibilities, Dr. Menegatti is actively involved in graduate-level mentoring, guiding students in the Biological Sciences postgraduate program. His contributions extend to organizing workshops, coordinating seminars, and participating in extension activities, reflecting his commitment to advancing pharmaceutical education and research.

Research Interests

Dr. Ricardo Menegatti’s research interests lie at the intersection of pharmaceutical chemistry and medicinal chemistry, with a particular focus on the design, synthesis, and pharmacological evaluation of biologically active compounds. His work primarily revolves around the development of neuroactive drug prototypes, targeting the GABAergic system to explore potential treatments for neurological disorders such as schizophrenia, anxiety, and sleep disorders. Additionally, Dr. Menegatti is engaged in the discovery of new analgesic and antipsychotic agents, leveraging his expertise in molecular modeling and structure-activity relationships (SAR) to enhance drug efficacy and safety. His research also extends to the use of solid-phase synthesis and enzymatic catalysis in drug development, aiming to innovate in the creation of new therapeutic agents. Through his work, Dr. Menegatti contributes to the advancement of medicinal chemistry, striving to address critical challenges in the treatment of mental health disorders.

Awards and Recognition

Dr. Menegatti’s academic and research excellence has been recognized through various awards and honors throughout his career. As a recipient of scholarships from the National Council for Scientific and Technological Development (CNPq) in Brazil, he has demonstrated a strong commitment to advancing scientific knowledge. His leadership in organizing workshops and seminars further highlights his contributions to the academic community, earning him recognition among his peers and students.

Conclusion

Dr. Ricardo Menegatti’s extensive research contributions in medicinal chemistry, particularly in the development of neuroactive and antipsychotic drug candidates, make him a strong candidate for the Research for Best Researcher Award. His work has a significant geographic impact, with potential applications in global healthcare. While his research is primarily focused on pharmaceutical sciences, its implications extend to broader areas such as infectious diseases. Dr. Menegatti’s collaborative efforts, applied research, and academic leadership further solidify his suitability for this prestigious award.

Publications Top Notes

LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety Treatment

Journal: International Journal of Molecular Sciences
Date: September 26, 2023
DOI: 10.3390/ijms241914575

Bioanalytical LC-QTOF/MS Method for a N-phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies

Journal: Pharmaceuticals
Date: June 26, 2023
DOI: 10.3390/ph16070930

Antileishmanial Activity of the Chalcone Derivative LQFM064 Associated with Reduced Fluidity in the Parasite Membrane as Assessed by EPR Spectroscopy

Journal: European Journal of Pharmaceutical Sciences
Date: August 2020
DOI: 10.1016/j.ejps.2020.105407

Toxico-Pharmacological Evaluations of the Small-Molecule LQFM166: Inducer of Apoptosis and MDM2 Antagonist

Journal: Chemico-Biological Interactions
Date: September 2018
DOI: 10.1016/j.cbi.2018.07.004

Dr. Shaymaa Kassab : Leading Researcher in Medicinal Chemistry

Associate Professor of Medicinal Chemistry , Damanhour university, Egypt

She remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 She successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

B.Sc. in Pharmaceutical Sciences (1997-2002) from the Faculty of Pharmacy, Helwan University, Cairo, Egypt. M.Sc. in Pharmaceutical Chemistry (2002-2006) with a thesis on “Synthesis of Some Novel Glycosides of Expected Chemotherapeutic Activity” from the Faculty of Pharmacy, Helwan University, Egypt. Ph.D. in Pharmaceutical Chemistry (2007-2009) with a dissertation on “Synthesis of Certain Indole Derivatives of Expected Biological Activity” from the Faculty of Pharmacy, Cairo University, Egypt.

Skills:

Computational Chemistry: Proficient in using Molsoft ICM 3.4-8c, MOE, LeadiT, and SeeSAR 9 programs for docking flexible ligands and molecularly edited compounds into rigid proteins on the Windows operating system. Spectroscopy: Skilled in operating Nicolette FT/IR and Shimadzu spectrophotometers. Purification Systems: Experienced in operating the CombiFlash® Automated purification system. NMR Spectroscopy: Proficient in operating automated Bruker 400 MHz NMR and Varian NMR 400 spectrophotometers. Mass Spectrometry: Capable in operating the Amazon Ion trap ESI Mass Spectrophotometer.

Shaymaa Kassab ‘s citation metrics and indices from Google Scholar are as follows:

Cited by: All: 252, Since 2018: 221

Citations: 252 (All), 221 (Since 2018)

h-index: 9 (All), 9 (Since 2018)

i10-index: 9 (All), 9 (Since 2018)

These metrics showcase the impact of Kassab ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Academic Experience:

2002-2007: Teaching Assistant (B.Sc.) for practical sessions of Physical, Organic, and Pharmaceutical Chemistry courses at the Faculty of Pharmacy, Misr International University. 2007-2009: Teaching Assistant (M.Sc.) of Pharmaceutical Chemistry at the Faculty of Pharmacy, Misr International University. Address: Department of Pharmaceutical Chemistry, 425 El-Nargess Buildings, North Teseen St. (3rd Floor, Apt 8), New Cairo 11835, Faculty of Pharmacy, Damanhour Univ., Cairo, Egypt. Home Address: Galal Koreitam Square, Damanhour City 27. Contact Information: Mobile: +20-100-5267-570, Zip Code: 22516, Tel.: +20(45)3368069, Fax: +20(45)3368069, Email: shaymaakassab@yahoo.com, shaymaa.kassab@pharm.dmu.edu.eg. 2009-2011: Assistant Professor of Medicinal Chemistry, Supervisor of practical Pharmaceutical Chemistry courses at the Faculty of Pharmacy, Misr International University. Executive member in the Faculty’s Curriculum Committee and Exam Assessment and Examination Control Committee. 2010-2014: Lectured pharmacy students in Pharmaceutical Chemistry and Drug Design courses. Supervised one Master’s thesis entitled “Molecular design and synthesis of histone deacetylase inhibitors as antineoplastic agents,” which was awarded the degree.

Research Activities:

2014: Visiting Scholar at the University of Maryland in Baltimore, School of Pharmacy – Pharmaceutical Sciences Department, via a personal grant. 2016: Visiting Scholar at Virginia Commonwealth University, School of Pharmacy – Medicinal Chemistry Department, via a scientific mission offered by the Cultural Affairs and Missions Sector of the Ministry of Higher Education in Egypt. 2016: Visiting Scholar at Texas A&M University, College of Pharmacy – Pharmaceutical Sciences Department, via a scientific mission offered by the Cultural Affairs and Missions Sector of the Ministry of Higher Education in Egypt. 2017: Certified Outstanding Reviewer of the European Journal of Medicinal Chemistry.

Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award